Lingohr & Partner Asset Management Gmb H Abb Vie Inc. Transaction History

Lingohr & Partner Asset Management Gmb H

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 07, 2020	SELL	$64.5 - $97.79 $838,500 - $1.27 Million	-13,000 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$72.13 - $90.25 $425,567 - $532,475	5,900 Added 83.1%	13,000 $1.15 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $466,470 - $596,258	7,100 New	7,100 $516,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Lingohr & Partner Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Lingohr & Partner Asset Management Gmb H with notifications on news.